REVVITY, INC Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
REVVITY, INC (RVTY) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $142.15 per share for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-02-24
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2016-04-03 was $12.95, a 41.14% decline year-over-year.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2015-03-29 was $22.00, a 4.91% increase year-over-year.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2014-03-30 was $20.97, a 7.13% decline year-over-year.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for the quarter ending 2013-03-31 was $22.58.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2025 was $142.15, a 13.07% decline from fiscal 2024.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2024 was $163.53, a 5.93% increase from fiscal 2023.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $154.37, a 7.49% increase from fiscal 2023.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2023 was $143.62.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-12-28 | $142.15 10-K · filed 2026-02-24 | |||
| 2024-12-29 | $163.53 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $154.37 10-K · filed 2024-02-27 | |||
| 2023-01-01 | $143.62 10-K · filed 2023-03-01 | |||
| 2019-12-29 | $95.74 10-K · filed 2021-03-02 | |||
| 2018-12-30 | $75.52 10-K · filed 2020-02-25 | |||
| 2017-01-01 | $12.95 10-K · filed 2017-02-28 | |||
| 2016-10-02 | $12.95 10-Q · filed 2016-11-08 | |||
| 2016-07-03 | $12.95 10-Q · filed 2016-08-09 | |||
| 2016-04-03 | $12.95 10-Q · filed 2016-05-10 | |||
| 2016-01-03 | $20.20 10-K · filed 2016-03-01 | |||
| 2015-10-04 | $22.49 10-Q · filed 2015-11-10 | |||
| 2015-06-28 | $22.49 10-Q · filed 2015-08-04 | |||
| 2015-03-29 | $22.00 10-Q · filed 2015-05-05 | |||
| 2014-12-28 | $20.97 10-K · filed 2016-03-01 | |||
| 2014-09-28 | $20.97 10-Q · filed 2014-11-04 | |||
| 2014-06-29 | $20.97 10-Q · filed 2014-08-05 | |||
| 2014-03-30 | $20.97 10-Q · filed 2014-05-06 | |||
| 2013-12-29 | $22.88 10-K · filed 2016-03-01 | |||
| 2013-09-29 | $22.63 10-Q · filed 2013-11-05 | |||
| 2013-06-30 | $22.63 10-Q · filed 2013-08-06 | |||
| 2013-03-31 | $22.58 10-Q · filed 2013-05-06 | |||
| 2012-12-30 | $22.34 10-K · filed 2015-02-24 | |||
| 2012-01-01 | $30.29 10-K · filed 2014-02-25 | |||
| 2011-01-02 | $25.19 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |